• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 17
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 33
  • 11
  • 10
  • 10
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
31

Avaliação da inflamação miocárdica na doença de Chagas por ressonância magnética cardiovascular / Detection of myocardial inflammation in Chagas\' heart disease by cardiac magnetic resonance

Jorge Andion Torreão 12 March 2015 (has links)
INTRODUÇÃO: A cardiopatia chagásica (CC) é um importante problema de saúde pública na América do Sul e a patogênese desta doença ainda não é totalmente compreendida, mas a inflamação e a fibrose miocárdica participam de forma central no processo crônico e progressivo de dano miocárdico. Trabalho prévio de nosso grupo demonstrou a capacidade da Ressonância Magnética Cardiovascular (RMC) de identificar precisamente a fibrose miocárdica em pacientes com Doença de Chagas. A RMC demonstrou ser eficaz para avaliar edema miocárdico, como marcador de inflamação, e ser altamente sensível para a detecção de trombos intracavitários, especialmente no ventrículo esquerdo, e em outras patologias, como miocardites e infartos. A avaliação de edema miocárdio pela RMC em pacientes com CC não foi ainda avaliada na literatura. Nosso objetivo foi investigar a presença de edema e fibrose miocárdica nas três formas clínicas da CC, o que julgamos ser de potencial valor diagnóstico e prognóstico. MÉTODOS: Cinquenta e quatro pacientes com doença de chagas foram analisados: 16 pacientes com a forma indeterminada (FI), 17 pacientes com CC-SD e 21 pacientes com CC-CD. Todos os pacientes foram submetidos a exame de RMC em equipamento de 1,5 T, utilizando a sequência de realce tardio do miocárdio (RTM), a sequência de edema miocárdico (Spin-eco ponderado em T2) e a sequência de realce global precoce ponderado T1 pós-contraste, para identificar fibrose, edema e hiperemia miocárdicos, respectivamente. RESULTADOS: A fibrose miocárdica foi encontrada em 39 indivíduos, 72,2% de toda a amostra. A fibrose miocárdica foi detectada em 2 pacientes (12,5%) na forma indeterminada, com uma massa de fibrose média de 0,85 ± 2,47g. Os pacientes da forma CC-SD em sua quase totalidade - 16 pacientes (94,1%) - apresentaram fibrose, com uma massa média de 13,0 ± 10,8g. Todos os pacientes com a forma CC-CD apresentaram fibrose miocárdica (21 pacientes) e adicionalmente detinham a maior massa de fibrose média, 25 ± 11,9g. O edema miocárdico foi encontrado em 40 indivíduos, 74,0% de toda a amostra. A extensão do edema miocárdico foi analisada pelo número de segmentos comprometidos. Foram identificados 3 pacientes (18,8%) da forma indeterminada com critérios positivos para edema miocárdio, determinando uma média de 0,31 ± 0,87 segmentos. A forma CC-SD obteve a presença de edema em 16 indivíduos (94,1%) distribuídos em uma média de 3,24 ± 2,3 segmentos. Todos os pacientes da forma CC-CD apresentaram edema miocárdico pela RMC, em uma média 3,67 ± 1,82 segmentos (p < 0,001). Houve correlação significativa entre a quantidade de fibrose miocárdica e edema miocárdico com a gravidade das formas clínicas (p < 0,001), classe funcional (p < 0,001), fração de ejeção do VE (p < 0,001) e volume diastólico do VE(p < 0,001). CONCLUSÃO: Fibrose e inflamação miocárdica foram detectadas pela ressonância magnética cardíaca em pacientes portadores de cardiopatia chagásica em todas as fases crônicas da doença, inclusive naqueles pacientes sem cardiopatia ou com cardiopatia sem disfunção ventricular. A quantidade de fibrose e edema miocárdico apresenta correlação com a gravidade da forma clínica, classe funcional, fração de ejeção do VE e dilatação do VE / BACKGROUND AND PURPOSE: Chagas\' heart disease (CHD) is a major public health problem in South America, and the pathogenesis of this disease is not yet fully understood, but inflammation and myocardial fibrosis seem to play a central role in the process of chronic and progressive myocardial damage. Previous descriptions from our group demonstrated the ability of Cardiovascular Magnetic Resonance (CMR) accurately identify myocardial fibrosis in patients with CHD. CMR shown to be effective for assessing myocardial edema, a marker of inflammation, and is highly sensitive for the detection of thrombi, especially in the left ventricle in other pathologies such as myocarditis and myocardial infarct. The assessment of myocardial edema by CMR in patients with CHD has not been evaluated. We believe to be of potential diagnostic and prognostic value to investigate the presence of myocardial edema and fibrosis in patients in the three clinical forms of this disease. METHODS: Fifty-four patients with Chagas\' disease were analyzed: 16 patients with the indeterminate phase (IF), 17 patients with the cardiac form without left ventricular systolic dysfunction (CFWO), and 21 patients with the cardiac form with left ventricular systolic dysfunctional form (CFSD). All patients underwent 1.5-T cardiac magnetic resonance (CMR) using the myocardial delayed enhancement sequence (MDE), T2-weighted sequence and the T1 weighted global enhancement after contrast sequence, to identify fibrosis, edema and hyperemia, respectively. RESULTS: Myocardial fibrosis was found in 39 subjects, 72.2% of the entire sample. Myocardial fibrosis was detected in 2 patients (12.5%) with the indeterminate form, representing an average mass of fibrosis of 0.85 ± 2.47 g. Patients with the CFWO almost entirely, 16 patients (94.1%) showed fibrosis, representing an average mass of fibrosis of 13.0 ± 10.8 g. All patients with the CFSD had myocardial fibrosis (21 patients) additionally had greater average mass of fibrosis 11.9 ± 25g. The myocardial edema was found in 40 subjects, 74.0% of the entire sample. The extent of myocardial edema was determined by the number of segments affected. We identified three patients (18.8%) from the indeterminate form with myocardial edema, an average of 0.31 ± 0.87. The CFWO presented a high presence of edema in 16 individuals (94.1%) distributed in an average of 3.24 ± 2.3 segments. All patients with the CFSD presented myocardial edema, an average of 3.67 ± 1.82 segments. (p < 0.001). There was significant correlation between the amount of myocardial fibrosis and myocardial edema with the severity of the clinical forms ( p < 0.001 ), functional class ( p < 0.001 ), LV ejection fraction ( p < 0.001 ) and left ventricular diastolic volume ( p < 0.001). CONCLUSION: Myocardial fibrosis and inflammation were detected by cardiac magnetic resonance imaging in patients with Chagas\' disease in all stages of chronic disease, including those patients without heart disease or cardiomyopathy without ventricular dysfunction. The amount of fibrosis and myocardial edema correlates with the severity of the clinical, functional class, LV ejection fraction and LV dilation
32

Autoregulation of the Human Cerebrovasculature by Neurovascular Coupling

Farr, Hannah Abigail January 2013 (has links)
Functional hyperaemia is an important mechanism by which increased neuronal activity is matched by a rapid and regional increase in blood supply. This mechanism is facilitated by a process known as “neurovascular coupling” – the orchestrated communication system involving the cells that comprise the neurovascular unit (neurons, astrocytes and the smooth muscle and endothelial cells lining arterioles). Blood flow regulation and neurovascular coupling are altered in several pathological states including hypertension, diabetes, Alzheimer’s disease, cortical spreading depression and stroke. By adapting and extending other models found in the literature, we create, for the first time, a mathematical model of the entire neurovascular unit that is capable of simulating two separate neurovascular coupling mechanisms: a potassium- and EET-based and a NO-based mechanism. These models successfully account for several observations seen in experiment. The potassium/EET-based mechanism can achieve arteriolar dilations similar in magnitude (3%) to those observed during a 60-second neuronal activation (modelled as a release of potassium and glutamate into the synaptic cleft). This model also successfully emulates the paradoxical experimental finding that vasoconstriction follows vasodilation when the astrocytic calcium concentration (or perivascular potassium concentration) is increased further. We suggest that the interaction of the changing smooth muscle cell membrane potential and the changing potassium-dependent resting potential of the inwardly rectifying potassium channel are responsible for this effect. Furthermore, our simulations demonstrate that the arteriolar behaviour is profoundly affected by depolarization of the astrocytic cell membrane, and by changes in the rate of perivascular potassium clearance or the volume ratio between the perivascular space and astrocyte. In the modelled NO-based neurovascular coupling mechanism, NO exerts its vasodilatory effects via neuronal and endothelial cell sources. With both sources included, the model achieves a 1% dilation due to a 60-second neuronal activation. When the endothelial contribution to NO production is omitted, the arteriole is more constricted at baseline. Without the endothelial NO contribution, the arteriolar change in diameter during neuronal activity is greater (6%). We hypothesize that NO has a dual purpose in neurovascular coupling: 1) it dixxxvi rectly mediates neurovascular coupling through release by neuronal sources, and 2) it indirectly modulates the size of the neurovascular coupling response by determining the baseline tone. Our physiological models of neurovascular coupling have allowed us to replicate, and explain, some of the phenomena seen in both neurovascular coupling-oriented and clinicallyoriented experimental research. This project highlights the fact that physiological modelling can be used as a tool to understand biological processes in a way that physical experiment cannot always do, and most importantly, can help to elucidate the cellular processes that induce or accompany our most debilitating diseases.
33

Kardiovaskulární rizika u chronického onemocnění dýchacích cest v dětském věku / Cardiovascular Risks in Chronic Airway Disease in Childhood

Kreslová, Marcela January 2020 (has links)
1 Cardiovascular risks in chronic airway disease in childhood The aim of this thesis was to evaluate cardiovascular risk by using a combined diagnostic approach by measuring RHI and specific biochemical markers in patients with chronic respiratory disease, where we could assume a possible risk of CVD. A total of 119 probands were examined, including 22 patients with cystic fibrosis (CF) and 52 asthma patients. We evaluated RHI using a new plethysmographic method that has a number of advantages over the ultrasonographic methods used in other studies, including non-invasiveness, high sensitivity, low biological variability and objectivity due to automatic processing. Of the biochemical parameters, we measured 4 biomarkers in relation to endothelial dysfunction (ED): hsCRP, ADMA, E-selectin, and VCAM-1. We compared RHI and biomarkers in CF and asthma patients with healthy controls and sought mutual correlations. We did not prove a statistically significant difference in RHI between the test groups with CF children but we confirmed the decreasing trend of RHI since adolescence and significantly lower RHI values in CF adults, confirming the progressive development of atherogenesis and worsening of ED with age. Biochemical parameters showed significantly higher levels of hsCRP, sVCAM-1 and E-selectin in CF...

Page generated in 0.0395 seconds